Chemical Compound
(2E)-N-((2S,3R,4R,5R,6R)-2-(((2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-((2R)-2-((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)-2-hydroxyethyl)-4,5-dihydroxytetrahydro-2H-pyran-3-yl)-12-methyltridec-2-enamide;(5'R)-5'-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(11)-2,6-dideoxy-2-(12-methyltridec-2-enamido)-beta-D-galactopyranos-6-yl)uridine
CAS Registry Number
66081-37-6
Primary record
(2E)-N-((2S,3R,4R,5R,6R)-2-(((2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-((2R)-2-((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)-2-hydroxyethyl)-4,5-dihydroxytetrahydro-2H-pyran-3-yl)-12-methyltridec-2-enamide;(5'R)-5'-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(11)-2,6-dideoxy-2-(12-methyltridec-2-enamido)-beta-D-galactopyranos-6-yl)uridine
- 库存
- 9,667 克
- 纯度
- 99.0 %
- CAS
- 66081-37-6
化合物标识与属性
- CAS
- 66081-37-6
- PubChem CID
- 56927832
- SMILES
- CC(C)CCCCCCCC/C=C/C(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)NC(=O)C)C[C@H]([C@@H]3[C@H]([C@H]([C@@H](O3)N4C=CC(=O)NC4=O)O)O)O)O)O
- Canonical SMILES
- CC(=O)N[C@H]1[C@@H](O[C@@H]2O[C@H](C[C@@H](O)[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)[C@H](O)[C@H](O)[C@H]2NC(=O)/C=C/CCCCCCCCC(C)C)O[C@H](CO)[C@@H](O)[C@@H]1O
名称与同义词
- tunicamycin C
- Tunicamycin A1
- tunicamycin II
- tunicamycin
- A1-tunicamycin
- streptovirudin C2
- Tunicamycin 14:1
- RefChem:192543
- UNII-15L186IOS4
- 15L186IOS4
- CHEBI:64245
- SCHEMBL21597950
- C37H60N4O16
- C37-H60-N4-O16
- J742.142G
- 66081-37-6
- Q27133153
- (2E)-N-[(2S,3R,4R,5R,6R)-2-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-6-{(2R)-2-[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-2-hydroxyethyl}-4,5-dihydroxytetrahydro-2H-pyran-3-yl]-12-methyltridec-2-enamide
- (5'R)-5'-[2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(1<->1)-2,6-dideoxy-2-(12-methyltridec-2-enamido)-beta-D-galactopyranos-6-yl]uridine
- (2E)-N-((2S,3R,4R,5R,6R)-2-(((2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-((2R)-2-((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)-2-hydroxyethyl)-4,5-dihydroxytetrahydro-2H-pyran-3-yl)-12-methyltridec-2-enamide;(5'R)-5'-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(11)-2,6-dideoxy-2-(12-methyltridec-2-enamido)-beta-D-galactopyranos-6-yl)uridine
- (2E)-N-[(2S,3R,4R,5R,6R)-6-[(2R)-2-[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-2-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,5-dihydroxyoxan-3-yl]-12-methyltridec-2-enamide
- (E)-N-((2S,3R,4R,5R,6R)-2-((2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-6-((2R)-2-((2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl)-2-hydroxyethyl)-4,5-dihydroxyoxan-3-yl)-12-methyltridec-2-enamide
- 2,4(1H,3H)-Pyrimidinedione, 1-((10(E),11S)-11-O-(2-(acetylamino)-2-deoxy-alpha-D-glucopyranosyl)-6-10,dideoxy-10-((12-methyl-1-oxo-2-tridecenyl)amino)-L-galacto-beta-D-allo-undecodialdo-1,4-furanose-11,7-pyranos-1-yl)-
- 2,4(1H,3H)-PYRIMIDINEDIONE, 1-((11S)-11-O-(2-(ACETYLAMINO)-2-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL)-6,10-DIDEOXY-10-(((2E)-12-METHYL-1-OXO-2-TRIDECEN-1-YL)AMINO)-L-GALACTO-.BETA.-D-ALLO-UNDECODIALDO-1,4-FURANOSE-11,7-PYRANOS-1-YL)-
- 2,4(1H,3H)-Pyrimidinedione, 1-[(11S)-11-O-[2-(acetylamino)-2-deoxy-alpha-D-glucopyranosyl]-6,10-dideoxy-10-[[(2E)-12-methyl-1-oxo-2-tridecen-1-yl]amino]-L-galacto-beta-D-allo-undecodialdo-1,4-furanose-11,7-pyranos-1-yl]-
- TUM